Definitive Contract HHSN261200433009C
Award Date 5/15/04
Potential Completion Date 11/1/12
Potential Value $43M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Philadelphia, PA 19111, USA
Solicitation Procedures
Not listed
Number Of Offers Received
5
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the National Cancer Institute (NCI), a division of the National Institutes of Health (NIH), to Fox Chase Cancer Center, a non-profit hospital. The contract, titled "CANCER INFORMATION SERVICE", has a ceiling value of $19,632,116.00 and is a definitive contract with cost-no-fee pricing. The contract does not have a set-aside designation. The contract was awarded on January 15, 2005 with a planned completion date of January 14, 2010. Fox Chase Cancer...
- <p>The National Heart Lung and Blood Institute awarded a purchase order to Fox Chase Cancer Center for $50,274.07, with an award date of September 1, 2011 and completion by August 31, 2012. Work is performed in Philadelphia, Pennsylvania. The order covers other professional services on a firm fixed price basis with no set-aside.</p>
- The federal contract award is for a "Patterns of Care/Quality of Care Study (POC): Diagnosis Year 2016" to be performed by the Fred Hutchinson Cancer Research Center, a non-profit organization. The contract has a ceiling value of $75,367.00 and was awarded on July 31, 2017 by the National Cancer Institute, a civilian agency within the Department of Health and Human Services. The contract is a firm fixed price delivery order, with an ultimate completion date of July 30, 2018. This...
- This $5,635,564.60 cost-reimbursable definitive contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Fred Hutchinson Cancer Center (doing business as Seattle Cancer Care Alliance), a non-profit medical research organization. The contract supports targeted clinical research to address select viral infections. There was no set-aside designation. Under the contract, Fred Hutchinson Cancer Center is...
- This is a firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency, to the Fred Hutchinson Cancer Research Center, a non-profit organization. The $52,423 contract is part of the NCI's Surveillance, Epidemiology, and End Results (SEER) program and is intended to improve the completeness of treatment and other key data elements by linking 15-month resubmitted data from Commission on Cancer (CoC) hospitals. The contract has an ultimate completion...
- The National Cancer Institute (NCI) awarded a $3,212,212 delivery order to the Fred Hutchinson Cancer Research Center, a non-profit organization, to provide core infrastructure support services. This award was not set aside and is part of the NCI's Surveillance, Epidemiology, and End Results (SEER) program, which conducts cancer research and patient care. The contract has a period of performance through May 31, 2014 and is a cost-no-fee type. Fred Hutchinson has held other federal contracts...
- This is a $547,860 delivery order contract awarded by the National Cancer Institute (NCI) of the Department of Health and Human Services (HHS) to The Institute for Cancer Research, a non-profit research organization. The contract is part of the Preclinical Efficacy and Intermediate Endpoint Biomarkers indefinite delivery vehicle, which supports the PREVENT Cancer Preclinical Drug Development Program. Under this 5-year IDIQ, The Institute for Cancer Research provides preclinical efficacy...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. government, has awarded a $306,500.00 firm fixed price definitive contract to Fox Chase Chemical Diversity Center Inc., a for-profit pharmaceutical organization. The contract, which does not have a set-aside designation, is for SBIR Topic 134 and has an ultimate completion date of November 14, 2025. Fox Chase Chemical Diversity Center Inc. is an experienced federal contractor, having received...
- This is a federal contract award from the Department of Health and Human Services National Institutes of Health National Cancer Institute to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract, valued at $67,882,919.00, is a cost-plus-fixed-fee delivery order for the PDX PANELS FROM COMMON TUMORS project. The work is to be performed at the Fort Detrick facility in Maryland and has a completion date of September 25, 2027. The contract does not have a set-aside...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $70,305.00 firm fixed price delivery order contract to the Fred Hutchinson Cancer Research Center, a non-profit organization, to conduct a Patterns of Care/Quality of Care study for the Surveillance, Epidemiology, and End Results (SEER) program. This contract was awarded without a set-aside designation and has a performance period from August 2015 to August 2016. The Fred Hutchinson...